Neurosterix
Dominik Schelshorn is an accomplished professional in the field of biology with extensive experience in drug development and research. Currently serving as Associate Director - Biology at Neurosterix since March 2024, Dominik focuses on advancing the understanding of allosteric modulators and enhancing drug development processes through innovation. Previously, Dominik held a similar position at Addex Therapeutics from August 2018 to May 2024, where efforts centered around developing new biological tools and frameworks for drug design. Dominik's earlier roles include Director of R&D at Geneva Biotech, Visiting Scientist at Université de Genève, Senior Scientist in Technology Development at Addex Therapeutics, and Research Scientist at the University of Heidelberg. Dominik earned a doctoral degree in Neurophysiology and holds multiple diplomas in Molecular and Cellular Biology and general Biology from Heidelberg University, alongside experience as a master student at the University of Portsmouth.
This person is not in any teams
Neurosterix
Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators — molecules that increase or decrease the activity of target receptors by binding outside of the “active site” where endogenous ligands and traditional drugs operate. Through this platform, Neurosterix’s novel drug candidates have the potential to provide medicines with improved efficacy, safety and tolerability for patient communities suffering from underserved neurological disorders.